CardioExchange Archive

CardioExchange, an NEJM practice community for medical professionals dedicated to improving cardiac patient care, was active from 2009 to 2015. CardioExchange fostered discussion between clinicians from across the globe.

November 18th, 2009

At the AHA: Continuous May Be Better Than Pulsatile Flow For Destination VADs

Among 200 patients ineligible for heart transplantation in the HeartMate II study, continuous-flow LVAD therapy was associated with a lower rate of the primary endpoint, freedom from stroke or device failure, when compared to pulsatile-flow destination therapy at 2 years.  Dr. William Abraham summarizes the findings and editorialist Dr. James Fang weighs in.

Categories: General


You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

Comments are closed.